David Goldstein

31.3k total citations · 4 hit papers
446 papers, 18.7k citations indexed

About

David Goldstein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, David Goldstein has authored 446 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Oncology, 106 papers in Pulmonary and Respiratory Medicine and 71 papers in Cancer Research. Recurrent topics in David Goldstein's work include Pancreatic and Hepatic Oncology Research (118 papers), Cancer Treatment and Pharmacology (78 papers) and Cancer Genomics and Diagnostics (64 papers). David Goldstein is often cited by papers focused on Pancreatic and Hepatic Oncology Research (118 papers), Cancer Treatment and Pharmacology (78 papers) and Cancer Genomics and Diagnostics (64 papers). David Goldstein collaborates with scholars based in Australia, United States and Canada. David Goldstein's co-authors include Susanna B. Park, Michael Friedländer, Matthew C. Kiernan, Phyllis Butow, Arun V. Krishnan, Minoti V. Apte, Malcolm J. Moore, Jeremy S. Wilson, Romano C. Pirola and Cindy Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Personality and Social Psychology.

In The Last Decade

David Goldstein

431 papers receiving 18.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

2007 2.9k citations David Goldstein et al. profile →
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

2016 685 citations David Goldstein et al. profile →
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

2013 558 citations Susanna B. Park, David Goldstein et al. profile →
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

2015 504 citations David Goldstein et al. profile →

Peers

Countries citing papers authored by David Goldstein

Since Specialization

Citations

This map shows the geographic impact of David Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Goldstein more than expected).

Fields of papers citing papers by David Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Goldstein. The network helps show where David Goldstein may publish in the future.

Co-authorship network of co-authors of David Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Goldstein. A scholar is included among the top collaborators of David Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Goldstein. David Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity 2024 ·Journal of the National Comprehensive Cancer Network ·(unknown), Tiffany Li, Hannah C. Timmins, Lisa G. Horvath, Michelle Harrison, Peter Grimison, Gavin Marx, David Goldstein, Susanna B. Park	6
2	Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity 2024 ·Journal of the Neurological Sciences ·(unknown), Tiffany Li, (unknown), Michelle Harrison, Sanjeev Kumar, Lisa G. Horvath, Peter Grimison, (unknown), David Goldstein, Susanna B. Park	3
3	Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy 2024 ·JCO Precision Oncology ·(unknown), Tiffany Li, Hui‐Ming Lin, Hannah C. Timmins, David Goldstein, Michelle Harrison, Michael Friedländer, Kate Mahon, Corey Giles, Peter J. Meikle, Susanna B. Park, Lisa G. Horvath	1
4	Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study 2022 ·Journal of Translational Medicine ·(unknown), David Goldstein, Hannah C. Timmins, Tiffany Li, Michelle Harrison, Michael Friedländer, Craig Lewis, Justin G. Lees, Gila Moalem‐Taylor, Boris Guennewig, Susanna B. Park, John B. Kwok	6
5	Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study 2022 ·Supportive Care in Cancer ·Megan Best, Nicci Bartley, Christine E. Napier, Alana Fisher, Mandy L. Ballinger, David M. Thomas, David Goldstein, Kathy Tucker, Barbara B. Biesecker, Phyllis Butow	4
6	The effect of exercise intensity on exercise‐induced hypoalgesia in cancer survivors: A randomized crossover trial 2021 ·Physiological Reports ·Briana K. Clifford, Matthew D. Jones, David Simar, B. Benjamin, David Goldstein	4
7	Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains framework 2020 ·BMJ Quality & Safety ·Ashika Maharaj, Sue Evans, John Zalcberg, Liane Ioannou, Marnie Graco, Daniel Croagh, Charles Pilgrim, (unknown), David Goldstein, Jennifer Philip, James G. Kench, Neil D. Merrett, Rachel Ε. Neale, Kate White, Peter Evans, Trevor Leong, Sally Green	16
8	Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework 2020 ·PLoS ONE ·Ashika Maharaj, Sue Evans, John Zalcberg, Liane Ioannou, Marnie Graco, Daniel Croagh, Charles Pilgrim, (unknown), David Goldstein, Jennifer Philip, James G. Kench, Neil D. Merrett, Rachel Ε. Neale, Kate White, Peter Evans, Trevor Leong, Sally Green	3
9	Patients’ Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer 2020 ·JNCI Cancer Spectrum ·Prunella Blinman, Andrew Martin, Michael Jefford, David Goldstein, David Boadle, (unknown), Niall C. Tebbutt, (unknown), Andrea Harkin, Eva Segelov, Andrew Haydon, Timothy Iveson, Martin R. Stockler	4
10	Family communication about genomic sequencing: A qualitative study with cancer patients and relatives 2020 ·Patient Education and Counseling ·Amelia K. Smit, Nicci Bartley, Megan Best, Christine E. Napier, Phyllis Butow, Ainsley J. Newson, Kathy Tucker, Mandy L. Ballinger, David M. Thomas, Chris Jacobs, Bettina Meiser, David Goldstein, (unknown), Ilona Juraskova	10
11	Advanced cancer patient preferences for receiving molecular profiling results 2020 ·Psycho-Oncology ·Megan Best, Phyllis Butow, Chris Jacobs, Ilona Juraskova, (unknown), Bettina Meiser, David Goldstein, Mandy L. Ballinger, Nicci Bartley, Christine E. Napier, (unknown), David M. Thomas, Kathy Tucker, Timothy E. Schlub, Ainsley J. Newson, (unknown)	7
12	Patient perspectives on molecular tumor profiling: “Why wouldn’t you?” 2019 ·BMC Cancer ·(unknown), Megan Best, Nicci Bartley, Chris Jacobs, Ilona Juraskova, David Goldstein, Ainsley J. Newson, (unknown), Bettina Meiser, Mandy L. Ballinger, Christine E. Napier, David M. Thomas, Barbara B. Biesecker, Phyllis Butow	26
13	Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer 2018 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Yi Wan, (unknown), Marc Botteman, David Goldstein	1
14	A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. 2016 ·The Sydney eScholarship Repository (The University of Sydney) ·Vanessa L. Beesley, Monika Janda, David Goldstein, Helen Gooden, Neil D. Merrett, Dianne L. O’Connell, Ingrid J. Rowlands, David Wyld, Rachel Ε. Neale	47
15	Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines 2016 ·Anticancer Research ·Hui Jun Lim, Xiaochun Wang, Philip Crowe, David Goldstein, Jia‐Lin Yang	23
16	Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis 2010 ·American Journal Of Pathology ·Zhihong Xu, Alain Vonlaufen, Phoebe A. Phillips, Eva Fiala‐Beer, Xuguo Zhang, Lu Yang, Andrew V. Biankin, David Goldstein, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte	286
17	Abstract B32: Unmet needs in Chinese, Greek, and Arabic speaking cancer patients in Australia 2009 ·Cancer Epidemiology and Prevention Biomarkers ·Phyllis Butow, Maurice Eisenbruch, David Goldstein, (unknown), Michael Jefford, (unknown), Afaf Girgis, Madeleine King, (unknown), Ming Sze	4
18	Desmoplastic Reaction in Pancreatic Cancer 2004 ·Pancreas ·Minoti V. Apte, (unknown), Phoebe A. Phillips, Nicole Santucci, David Goldstein, Rakesh Kumar, Grant A. Ramm, Markus W. Büchler, Helmut Frieß, Joshua A. McCarroll, G. Keogh, Neil D. Merrett, Romano C. Pirola, Jeremy S. Wilson	490
19	Advances in Computational Methods in Fluid Dynamics 1994 ·Infoscience (Ecole Polytechnique Fédérale de Lausanne) ·Asme, (unknown), Urmila Ghia, David Goldstein	5
20	Vietnamese Women and Children Refugees in Hong Kong: An Argument against Arbitrary Detention 1993 ·Duke journal of comparative & international law ·(unknown), David Goldstein	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact